Murray K - Search Results

1

Novel growth inhibitory effect of 8-Cl-cAMP is dependent on serum factors that modulate protein kinase A expression but not the hydrolysis of 8-Cl-cAMP.

Budillon A, Clair T, Hartman N, Strong J, Sobukawa Y, Miki K, Worby A, Murray K, Chochung Y. Budillon A, et al. Among authors: murray k. Int J Oncol. 1996 Dec;9(6):1113-20. doi: 10.3892/ijo.9.6.1113. Int J Oncol. 1996. PMID: 21541619

2

Relaxation of guinea-pig trachea by cyclic AMP phosphodiesterase inhibitors and their enhancement by sodium nitroprusside.

Turner NC, Lamb J, Worby A, Murray KJ. Turner NC, et al. Among authors: murray kj. Br J Pharmacol. 1994 Apr;111(4):1047-52. doi: 10.1111/j.1476-5381.1994.tb14850.x. Br J Pharmacol. 1994. PMID: 8032589 Free PMC article.

3

Identification of the novel rat liver IBMX-insensitive phosphodiesterase as a non-specific phosphodiesterase capable of hydrolysing cCMP.

Worby A, Mensah LM, Murray KJ. Worby A, et al. Among authors: murray kj. Biochem Pharmacol. 1991 Aug 22;42(6):1318-21. doi: 10.1016/0006-2952(91)90274-9. Biochem Pharmacol. 1991. PMID: 1716099 No abstract available.

4

Myofibrillar bound cyclic nucleotide phosphodiesterase in heart and skeletal muscle.

Worby A, Mensah LM, Murray KJ. Worby A, et al. Among authors: murray kj. Biochem Soc Trans. 1992 May;20(2):129S. doi: 10.1042/bst020129s. Biochem Soc Trans. 1992. PMID: 1327896 No abstract available.

5

The effect of SK&F 95654, a novel phosphodiesterase inhibitor, on cardiovascular, respiratory and platelet function.

Murray KJ, Eden RJ, Dolan JS, Grimsditch DC, Stutchbury CA, Patel B, Knowles A, Worby A, Lynham JA, Coates WJ. Murray KJ, et al. Br J Pharmacol. 1992 Oct;107(2):463-70. doi: 10.1111/j.1476-5381.1992.tb12768.x. Br J Pharmacol. 1992. PMID: 1422592 Free PMC article.

6

Pulmonary effects of type V cyclic GMP specific phosphodiesterase inhibition in the anaesthetized guinea-pig.

Turner NC, Dolan JS, Grimsditch D, Lamb J, Worby A, Murray KJ, Coates WJ, Warrington BH. Turner NC, et al. Among authors: murray kj. Br J Pharmacol. 1994 Apr;111(4):1198-204. doi: 10.1111/j.1476-5381.1994.tb14872.x. Br J Pharmacol. 1994. PMID: 8032606 Free PMC article.

7

Potential use of selective phosphodiesterase inhibitors in the treatment of asthma.

Murray KJ, Eden RJ, England PJ, Dolan J, Grimsditch DC, Stutchbury CA, Patel B, Reeves ML, Worby A, Torphy TJ, et al. Murray KJ, et al. Agents Actions Suppl. 1991;34:27-46. Agents Actions Suppl. 1991. PMID: 1665307

8

Use of a synthetic dodecapeptide (malantide) to measure the cyclic AMP-dependent protein kinase activity ratio in a variety of tissues.

Murray KJ, England PJ, Lynham JA, Mills D, Schmitz-Peiffer C, Reeves ML. Murray KJ, et al. Biochem J. 1990 May 1;267(3):703-8. doi: 10.1042/bj2670703. Biochem J. 1990. PMID: 2160235 Free PMC article.

9

Cyclic AMP and mechanisms of vasodilation.

Murray KJ. Murray KJ. Pharmacol Ther. 1990;47(3):329-45. doi: 10.1016/0163-7258(90)90060-f. Pharmacol Ther. 1990. PMID: 1963221 Review.

10

8-(4-Chlorophenyl)thio-cyclic AMP is a potent inhibitor of the cyclic GMP-specific phosphodiesterase (PDE VA).

Connolly BJ, Willits PB, Warrington BH, Murray KJ. Connolly BJ, et al. Among authors: murray kj. Biochem Pharmacol. 1992 Dec 15;44(12):2303-6. doi: 10.1016/0006-2952(92)90673-7. Biochem Pharmacol. 1992. PMID: 1335252

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,853 results

Search Page

Filters